questionsmedicales.fr
Thérapeutique
Radiothérapie
Radiothérapie : Questions médicales fréquentes
Termes MeSH sélectionnés :
Combined Modality Therapy
Diagnostic
5
Radiothérapie
Cancer
Diagnostic médical
Imagerie médicale
Radiothérapie
IRM
Oncologie
Radiothérapie
Médecin spécialiste
Cancer du sein
Cancer de la prostate
Radiothérapie
Radiothérapie
Prévention du cancer
Traitement du cancer
Symptômes
5
Effets secondaires
Radiothérapie
Symptômes
Nausées
Radiothérapie
Effets indésirables
Effets à long terme
Radiothérapie
Santé reproductive
Fatigue
Radiothérapie
Gestion des symptômes
Appétit
Radiothérapie
Effets secondaires
Prévention
5
Prévention du cancer
Radiothérapie
Traitement du cancer
Prévention du cancer
Mode de vie
Santé
Dépistage
Radiothérapie
Prévention du cancer
Vaccins
Prévention du cancer
HPV
Stress
Prévention du cancer
Santé mentale
Traitements
5
Radiothérapie externe
Curiethérapie
Radiothérapie
Chimiothérapie
Radiothérapie
Traitement combiné
Séances de traitement
Radiothérapie
Cancer
Douleur
Radiothérapie
Effets indésirables
Séance de radiothérapie
Radiothérapie
Procédure médicale
Complications
5
Complications
Radiothérapie
Effets indésirables
Cancers secondaires
Radiothérapie
Risques
Prévention
Complications
Suivi médical
Complications
Radiothérapie
Type de cancer
Soins post-traitement
Radiothérapie
Suivi médical
Facteurs de risque
5
Facteurs de risque
Cancer
Radiothérapie
Antécédents médicaux
Radiothérapie
Cancer
Sexe
Radiothérapie
Cancer
Alimentation
Facteurs de risque
Cancer
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Radiothérapie : Questions médicales les plus fréquentes",
"headline": "Radiothérapie : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Radiothérapie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-03",
"dateModified": "2025-04-28",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Radiothérapie"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Thérapeutique",
"url": "https://questionsmedicales.fr/mesh/D013812",
"about": {
"@type": "MedicalCondition",
"name": "Thérapeutique",
"code": {
"@type": "MedicalCode",
"code": "D013812",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Curiethérapie",
"alternateName": "Brachytherapy",
"url": "https://questionsmedicales.fr/mesh/D001918",
"about": {
"@type": "MedicalCondition",
"name": "Curiethérapie",
"code": {
"@type": "MedicalCode",
"code": "D001918",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chimioradiothérapie",
"alternateName": "Chemoradiotherapy",
"url": "https://questionsmedicales.fr/mesh/D059248",
"about": {
"@type": "MedicalCondition",
"name": "Chimioradiothérapie",
"code": {
"@type": "MedicalCode",
"code": "D059248",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.160"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Chimioradiothérapie adjuvante",
"alternateName": "Chemoradiotherapy, Adjuvant",
"url": "https://questionsmedicales.fr/mesh/D059186",
"about": {
"@type": "MedicalCondition",
"name": "Chimioradiothérapie adjuvante",
"code": {
"@type": "MedicalCode",
"code": "D059186",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.160.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Irradiation crânienne",
"alternateName": "Cranial Irradiation",
"url": "https://questionsmedicales.fr/mesh/D016371",
"about": {
"@type": "MedicalCondition",
"name": "Irradiation crânienne",
"code": {
"@type": "MedicalCode",
"code": "D016371",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.190"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Irradiation hypophysaire",
"alternateName": "Pituitary Irradiation",
"url": "https://questionsmedicales.fr/mesh/D010910",
"about": {
"@type": "MedicalCondition",
"name": "Irradiation hypophysaire",
"code": {
"@type": "MedicalCode",
"code": "D010910",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.190.600"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Irradiation craniospinale",
"alternateName": "Craniospinal Irradiation",
"url": "https://questionsmedicales.fr/mesh/D061888",
"about": {
"@type": "MedicalCondition",
"name": "Irradiation craniospinale",
"code": {
"@type": "MedicalCode",
"code": "D061888",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.230"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Radiothérapie par ions lourds",
"alternateName": "Heavy Ion Radiotherapy",
"url": "https://questionsmedicales.fr/mesh/D063193",
"about": {
"@type": "MedicalCondition",
"name": "Radiothérapie par ions lourds",
"code": {
"@type": "MedicalCode",
"code": "D063193",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.250"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protonthérapie",
"alternateName": "Proton Therapy",
"url": "https://questionsmedicales.fr/mesh/D061766",
"about": {
"@type": "MedicalCondition",
"name": "Protonthérapie",
"code": {
"@type": "MedicalCode",
"code": "D061766",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.250.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Irradiation hémicorporelle",
"alternateName": "Hemibody Irradiation",
"url": "https://questionsmedicales.fr/mesh/D017619",
"about": {
"@type": "MedicalCondition",
"name": "Irradiation hémicorporelle",
"code": {
"@type": "MedicalCode",
"code": "D017619",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.270"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Irradiation ganglionnaire",
"alternateName": "Lymphatic Irradiation",
"url": "https://questionsmedicales.fr/mesh/D015182",
"about": {
"@type": "MedicalCondition",
"name": "Irradiation ganglionnaire",
"code": {
"@type": "MedicalCode",
"code": "D015182",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.350"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Radioimmunothérapie",
"alternateName": "Radioimmunotherapy",
"url": "https://questionsmedicales.fr/mesh/D016499",
"about": {
"@type": "MedicalCondition",
"name": "Radioimmunothérapie",
"code": {
"@type": "MedicalCode",
"code": "D016499",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.520"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Radiothérapie adjuvante",
"alternateName": "Radiotherapy, Adjuvant",
"url": "https://questionsmedicales.fr/mesh/D018714",
"about": {
"@type": "MedicalCondition",
"name": "Radiothérapie adjuvante",
"code": {
"@type": "MedicalCode",
"code": "D018714",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dosimétrie en radiothérapie",
"alternateName": "Radiotherapy Dosage",
"url": "https://questionsmedicales.fr/mesh/D011879",
"about": {
"@type": "MedicalCondition",
"name": "Dosimétrie en radiothérapie",
"code": {
"@type": "MedicalCode",
"code": "D011879",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.639"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Fractionnement de la dose d'irradiation",
"alternateName": "Dose Fractionation, Radiation",
"url": "https://questionsmedicales.fr/mesh/D019583",
"about": {
"@type": "MedicalCondition",
"name": "Fractionnement de la dose d'irradiation",
"code": {
"@type": "MedicalCode",
"code": "D019583",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.639.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hypofractionnement de dose",
"alternateName": "Radiation Dose Hypofractionation",
"url": "https://questionsmedicales.fr/mesh/D000069473",
"about": {
"@type": "MedicalCondition",
"name": "Hypofractionnement de dose",
"code": {
"@type": "MedicalCode",
"code": "D000069473",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.639.200.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Hypofractionnement de dose",
"alternateName": "Radiation Dose Hypofractionation",
"url": "https://questionsmedicales.fr/mesh/D000069473",
"about": {
"@type": "MedicalCondition",
"name": "Hypofractionnement de dose",
"code": {
"@type": "MedicalCode",
"code": "D000069473",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.639.200.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Radiothérapie de haute énergie",
"alternateName": "Radiotherapy, High-Energy",
"url": "https://questionsmedicales.fr/mesh/D011882",
"about": {
"@type": "MedicalCondition",
"name": "Radiothérapie de haute énergie",
"code": {
"@type": "MedicalCode",
"code": "D011882",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.722"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thérapie par capture de neutrons",
"alternateName": "Neutron Capture Therapy",
"url": "https://questionsmedicales.fr/mesh/D017247",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie par capture de neutrons",
"code": {
"@type": "MedicalCode",
"code": "D017247",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.722.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thérapie par capture de neutrons par le bore",
"alternateName": "Boron Neutron Capture Therapy",
"url": "https://questionsmedicales.fr/mesh/D016754",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie par capture de neutrons par le bore",
"code": {
"@type": "MedicalCode",
"code": "D016754",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.722.500.100"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Thérapie par capture de neutrons par le bore",
"alternateName": "Boron Neutron Capture Therapy",
"url": "https://questionsmedicales.fr/mesh/D016754",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie par capture de neutrons par le bore",
"code": {
"@type": "MedicalCode",
"code": "D016754",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.722.500.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Télégammathérapie",
"alternateName": "Radioisotope Teletherapy",
"url": "https://questionsmedicales.fr/mesh/D011867",
"about": {
"@type": "MedicalCondition",
"name": "Télégammathérapie",
"code": {
"@type": "MedicalCode",
"code": "D011867",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.722.820"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Radiothérapie guidée par l'image",
"alternateName": "Radiotherapy, Image-Guided",
"url": "https://questionsmedicales.fr/mesh/D061089",
"about": {
"@type": "MedicalCondition",
"name": "Radiothérapie guidée par l'image",
"code": {
"@type": "MedicalCode",
"code": "D061089",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.768"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Radiothérapie X",
"alternateName": "X-Ray Therapy",
"url": "https://questionsmedicales.fr/mesh/D014964",
"about": {
"@type": "MedicalCondition",
"name": "Radiothérapie X",
"code": {
"@type": "MedicalCode",
"code": "D014964",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.907"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Radiothérapie",
"alternateName": "Radiotherapy",
"code": {
"@type": "MedicalCode",
"code": "D011878",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "David R Raleigh",
"url": "https://questionsmedicales.fr/author/David%20R%20Raleigh",
"affiliation": {
"@type": "Organization",
"name": "Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA. David.Raleigh@ucsf.edu."
}
},
{
"@type": "Person",
"name": "Baolin Qu",
"url": "https://questionsmedicales.fr/author/Baolin%20Qu",
"affiliation": {
"@type": "Organization",
"name": "Precision Medical Advanced Innovation Center, Beijing University of Aeronautics and Astronautics, Beijing, 100083."
}
},
{
"@type": "Person",
"name": "Gustavo Arruda Viani",
"url": "https://questionsmedicales.fr/author/Gustavo%20Arruda%20Viani",
"affiliation": {
"@type": "Organization",
"name": "Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (FMRP-USP), Ribeirão Preto, SP, Brazil."
}
},
{
"@type": "Person",
"name": "P A Coucke",
"url": "https://questionsmedicales.fr/author/P%20A%20Coucke",
"affiliation": {
"@type": "Organization",
"name": "Service de Radiothérapie, CHU Liège, Belgique."
}
},
{
"@type": "Person",
"name": "William C Chen",
"url": "https://questionsmedicales.fr/author/William%20C%20Chen",
"affiliation": {
"@type": "Organization",
"name": "Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, 94143, USA. william.chen@ucsf.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Survivorship in Early-Stage Rectal Cancer Patients Who Have Received Combined Modality Therapy.",
"datePublished": "2023-08-06",
"url": "https://questionsmedicales.fr/article/37586927",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.clcc.2023.08.002"
}
},
{
"@type": "ScholarlyArticle",
"name": "Combined modality therapy for patients with esophageal squamous cell carcinoma: Radiation dose and survival analyses.",
"datePublished": "2022-11-09",
"url": "https://questionsmedicales.fr/article/36351568",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/1759-7714.14724"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cost-Effectiveness of PET Directed Versus Combined Modality Therapy for Early-Stage Favorable Hodgkin's Lymphoma.",
"datePublished": "2022-07-17",
"url": "https://questionsmedicales.fr/article/35963771",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.clml.2022.07.005"
}
},
{
"@type": "ScholarlyArticle",
"name": "Assessment of Patient-Reported Outcomes in Patients With Anal Squamous-Cell Cancer Undergoing Combined Modality Therapy.",
"datePublished": "2022-09-05",
"url": "https://questionsmedicales.fr/article/36102865",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/DCR.0000000000002600"
}
},
{
"@type": "ScholarlyArticle",
"name": "PET-directed combined modality therapy for gastroesophageal junction cancer: Results of the multicentre prospective MEMORI trial of the German Cancer Consortium (DKTK).",
"datePublished": "2022-09-10",
"url": "https://questionsmedicales.fr/article/36099671",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejca.2022.07.027"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Thérapeutique",
"item": "https://questionsmedicales.fr/mesh/D013812"
},
{
"@type": "ListItem",
"position": 3,
"name": "Radiothérapie",
"item": "https://questionsmedicales.fr/mesh/D011878"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Radiothérapie - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Radiothérapie",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Radiothérapie",
"description": "Comment la radiothérapie est-elle diagnostiquée ?\nQuels examens précèdent la radiothérapie ?\nQui détermine le besoin de radiothérapie ?\nQuels types de cancers nécessitent la radiothérapie ?\nLa radiothérapie est-elle utilisée en prévention ?",
"url": "https://questionsmedicales.fr/mesh/D011878?mesh_terms=Combined+Modality+Therapy#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Radiothérapie",
"description": "Quels symptômes peuvent apparaître après la radiothérapie ?\nLa radiothérapie cause-t-elle des nausées ?\nY a-t-il des symptômes à long terme ?\nComment gérer la fatigue liée à la radiothérapie ?\nLa radiothérapie affecte-t-elle l'appétit ?",
"url": "https://questionsmedicales.fr/mesh/D011878?mesh_terms=Combined+Modality+Therapy#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Radiothérapie",
"description": "La radiothérapie peut-elle prévenir le cancer ?\nQuels modes de vie aident à prévenir le cancer ?\nLes dépistages aident-ils à éviter la radiothérapie ?\nLes vaccins peuvent-ils prévenir certains cancers ?\nLe stress influence-t-il le cancer ?",
"url": "https://questionsmedicales.fr/mesh/D011878?mesh_terms=Combined+Modality+Therapy#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Radiothérapie",
"description": "Quels types de radiothérapie existent ?\nLa radiothérapie est-elle combinée à d'autres traitements ?\nCombien de séances de radiothérapie sont nécessaires ?\nLa radiothérapie est-elle douloureuse ?\nComment se déroule une séance de radiothérapie ?",
"url": "https://questionsmedicales.fr/mesh/D011878?mesh_terms=Combined+Modality+Therapy#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Radiothérapie",
"description": "Quelles sont les complications possibles de la radiothérapie ?\nLa radiothérapie peut-elle causer des cancers secondaires ?\nComment prévenir les complications de la radiothérapie ?\nLes complications varient-elles selon le type de cancer ?\nQuels soins sont nécessaires après la radiothérapie ?",
"url": "https://questionsmedicales.fr/mesh/D011878?mesh_terms=Combined+Modality+Therapy#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Radiothérapie",
"description": "Quels sont les facteurs de risque pour le cancer traité par radiothérapie ?\nL'âge influence-t-il le besoin de radiothérapie ?\nLes antécédents médicaux influencent-ils la radiothérapie ?\nLe sexe joue-t-il un rôle dans le traitement par radiothérapie ?\nL'alimentation affecte-t-elle le risque de cancer ?",
"url": "https://questionsmedicales.fr/mesh/D011878?mesh_terms=Combined+Modality+Therapy#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment la radiothérapie est-elle diagnostiquée ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "La radiothérapie n'est pas diagnostiquée, mais elle est prescrite après un diagnostic de cancer."
}
},
{
"@type": "Question",
"name": "Quels examens précèdent la radiothérapie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens d'imagerie comme le scanner ou l'IRM sont souvent réalisés avant la radiothérapie."
}
},
{
"@type": "Question",
"name": "Qui détermine le besoin de radiothérapie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un oncologue est responsable de l'évaluation et de la prescription de la radiothérapie."
}
},
{
"@type": "Question",
"name": "Quels types de cancers nécessitent la radiothérapie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La radiothérapie est couramment utilisée pour les cancers du sein, de la prostate et du poumon."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle utilisée en prévention ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la radiothérapie est un traitement curatif, pas préventif, pour les cancers diagnostiqués."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent apparaître après la radiothérapie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, rougeur de la peau et douleurs localisées selon la zone traitée."
}
},
{
"@type": "Question",
"name": "La radiothérapie cause-t-elle des nausées ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des nausées peuvent survenir, surtout si la zone traitée est l'abdomen ou le cerveau."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes à long terme ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets à long terme peuvent inclure des changements cutanés ou des problèmes de fertilité."
}
},
{
"@type": "Question",
"name": "Comment gérer la fatigue liée à la radiothérapie ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé de se reposer, de bien s'hydrater et de suivre les conseils du médecin."
}
},
{
"@type": "Question",
"name": "La radiothérapie affecte-t-elle l'appétit ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent éprouver une perte d'appétit pendant le traitement."
}
},
{
"@type": "Question",
"name": "La radiothérapie peut-elle prévenir le cancer ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la radiothérapie est un traitement, pas un moyen de prévention du cancer."
}
},
{
"@type": "Question",
"name": "Quels modes de vie aident à prévenir le cancer ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation saine, l'exercice régulier et l'évitement du tabac peuvent aider à prévenir le cancer."
}
},
{
"@type": "Question",
"name": "Les dépistages aident-ils à éviter la radiothérapie ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dépistages réguliers peuvent détecter le cancer tôt, réduisant ainsi le besoin de radiothérapie."
}
},
{
"@type": "Question",
"name": "Les vaccins peuvent-ils prévenir certains cancers ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des vaccins comme celui contre le HPV peuvent prévenir certains cancers, comme le cancer du col de l'utérus."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il le cancer ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress n'est pas un facteur direct, mais un mode de vie sain peut aider à réduire le risque."
}
},
{
"@type": "Question",
"name": "Quels types de radiothérapie existent ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux types sont la radiothérapie externe et la radiothérapie interne (curiethérapie)."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle combinée à d'autres traitements ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est souvent combinée avec la chimiothérapie ou la chirurgie pour une efficacité accrue."
}
},
{
"@type": "Question",
"name": "Combien de séances de radiothérapie sont nécessaires ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le nombre de séances varie selon le type de cancer, généralement entre 5 et 30 séances."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle douloureuse ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la radiothérapie elle-même n'est pas douloureuse, mais des effets secondaires peuvent l'être."
}
},
{
"@type": "Question",
"name": "Comment se déroule une séance de radiothérapie ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le patient est positionné sur une table, et des rayons ciblés sont administrés sans douleur."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de la radiothérapie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des lésions tissulaires, des infections et des effets secondaires à long terme."
}
},
{
"@type": "Question",
"name": "La radiothérapie peut-elle causer des cancers secondaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il existe un risque faible de développer des cancers secondaires après une radiothérapie."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications de la radiothérapie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et le respect des recommandations du médecin aident à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon le type de cancer ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent varier selon la localisation et le type de cancer traité."
}
},
{
"@type": "Question",
"name": "Quels soins sont nécessaires après la radiothérapie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des soins de la peau, une bonne hydratation et un suivi médical sont essentiels après le traitement."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour le cancer traité par radiothérapie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le tabagisme, l'exposition à des substances cancérigènes et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le besoin de radiothérapie ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de cancer augmente avec l'âge, ce qui peut nécessiter une radiothérapie."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils la radiothérapie ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de cancer ou de radiothérapie peuvent influencer le traitement futur."
}
},
{
"@type": "Question",
"name": "Le sexe joue-t-il un rôle dans le traitement par radiothérapie ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines cancers sont plus fréquents chez un sexe, influençant ainsi le besoin de radiothérapie."
}
},
{
"@type": "Question",
"name": "L'alimentation affecte-t-elle le risque de cancer ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en fruits et légumes peut réduire le risque de certains cancers."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 28/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA. David.Raleigh@ucsf.edu.
Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA. David.Raleigh@ucsf.edu.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Precision Medical Advanced Innovation Center, Beijing University of Aeronautics and Astronautics, Beijing, 100083.
Department of Radiotherapy, PLA General Hospital, Beijing, 100853.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (FMRP-USP), Ribeirão Preto, SP, Brazil.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Service de Radiothérapie, CHU Liège, Belgique.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, 94143, USA. william.chen@ucsf.edu.
Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, 94143, USA. william.chen@ucsf.edu.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Johns Hopkins University, Baltimore, MD, 21287, USA.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Department of Radiation Oncology, Ohio State University, Columbus, OH, 43210, USA.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Department of Neurological Surgery, Northwestern University, Chicago, IL, 60611, USA.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Department of Cancer Center, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, Jiangsu 404100, China.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Klinik für Strahlentherapie und Radioonkologie, Universitätsklinikum Münster, Gebäude A1, Albert Schweitzer Campus, 48149, Münster, Deutschland. hans.eich@ukmuenster.de.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Department of Radiation Oncology, The Mayo Clinic, Rochester, MN, USA.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publications dans "Radiothérapie" :
1 publication dans cette catégorie
Affiliations :
University Hospital for Tumors, Sestre milosrdnice University Hospital Center.
Publications dans "Radiothérapie" :
1 publication dans cette catégorie
Affiliations :
Department of Radiation Oncology, University of Rochester, Rochester, NY 14642, USA.
Publications dans "Radiothérapie" :
1 publication dans cette catégorie
Affiliations :
Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA 90095, USA.
Publications dans "Radiothérapie" :
1 publication dans cette catégorie
Affiliations :
Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Publications dans "Radiothérapie" :
1 publication dans cette catégorie
Affiliations :
Department of Radiation Oncology, University of Rochester, Rochester, NY 14642, USA.
Publications dans "Radiothérapie" :
1 publication dans cette catégorie
Affiliations :
Department of Radiation Oncology, University of Rochester, Rochester, NY 14642, USA.
Publications dans "Radiothérapie" :
1 publication dans cette catégorie
Affiliations :
Dept. of Radiation Oncology, Graduate School of Biomedical and Health Sciences, Hiroshima University.
Publications dans "Radiothérapie" :
1 publication dans cette catégorie
Affiliations :
Department of Liver Surgery and Liver Transplantation, State Key Laboratory of Biotherapy and Cancer Center, Sichuan University and Collaborative Innovation Center of Biotherapy, West China Hospital, Chengdu, Sichuan 610000, P.R. China.
Publications dans "Radiothérapie" :
Survival rates in early-stage rectal cancer patients have increased over the past few decades. Societies such as the National Comprehensive Cancer Network (NCCN), American Cancer Society (ACS), Americ...
We aimed to analyze the radiation dose and compare survival among combined modality therapy using modern radiation techniques for patients with esophageal squamous cell carcinoma (ESCC)....
This retrospective study included patients with clinically staged T1-4N0-3M0 ESCC from 2014 to 2018. Patients who received combined modality therapies with curative intent were enrolled. The overall s...
Of the 259 patients, 141 (54.4%) received definitive concurrent chemoradiotherapy (DCCRT); 67 (25.9%) underwent neoadjuvant chemoradiotherapy followed by surgery (NCRT+S); 51 (19.7%) obtained surgery ...
Our results suggest that NCRT+S can provide a favorable survival for patients with ESCC, especially in patients who achieved pCR. The optimal radiation dose might be 55-60 Gy for patients receiving DC...
The standard of care for early-stage Hodgkin Lymphoma (HL) is combined modality therapy (CMT) consisting of chemotherapy and involved site radiation therapy (ISRT). Recent treatment de-escalation tria...
This study used a cost-effectiveness Markov model simulating 5 year outcomes for 1 million patients with early-stage HL treated with either PET-directed therapy consisting of 2 cycles of ABVD chemothe...
We found that PET-directed therapy and CMT strategies were associated with costs of $47,362 and $41,167, respectively. The CMT strategy was equally as effective as the PET-directed therapy strategy wi...
For patients with early-stage HL, CMT is the cost-effective strategy as compared with PET-directed therapy....
There is limited knowledge on long-term bowel, sexual, and urinary function after combined modality therapy for anal squamous-cell cancer....
This study aimed to evaluate long-term changes in patients treated with combined modality....
This was a retrospective study of prospectively collected patient-reported outcome surveys....
This study was conducted at a single institution....
There were 143 patients with stage I to III anal cancer who were treated with chemoradiation and had completed the survey....
This study included patient-reported outcomes reflecting bowel, sexual, and urinary function....
Thirty-nine percent of patients had major low anterior resection syndrome at baseline. Major low anterior resection syndrome remained stable (38%; 95% CI, 31%-46%) with no change over time (OR 0.95; 9...
This was a single-institution study and only patients who answered the questionnaire were included in the study....
A significant proportion of patients have major low anterior resection syndrome at baseline and after successful treatment for anal cancer. Having major low anterior resection syndrome at baseline was...
ANTECEDENTES:Existe un conocimiento limitado sobre la función intestinal, sexual y urinaria a largo plazo después de la terapia de modalidad combinada para el cáncer anal de células escamosas.OBJETIVO...
Positron emission tomography (PET) may differentiate responding and non-responding tumours early in the treatment of locally advanced gastroesophageal junction adenocarcinomas. Early PET non-responder...
Patients underwent baseline...
In total, 160 patients with resectable gastroesophageal junction adenocarcinomas were prospectively investigated by PET scanning. Eighty-five patients (53%) were excluded. Seventy-five eligible patien...
The primary endpoint of the study to increase the R0 resection rate in metabolic NR was not met. PET response after induction CTX is prognostic for outcome with a prolonged OS and DFS in PET responder...
NCT00002014-000860-16....
Facial aging involves multilevel changes, extending from the skin to deep support structures. A comprehensive treatment approach targeting the many aspects of facial dynamics and architecture is often...
To explore the integration of botulinum toxin type A (BoNT-A) into multimodal aesthetic treatment plans....
This article reviews evidence supporting the combination of BoNT-A with other minimally invasive cosmetic therapies, including dermal fillers, lasers, and energy-based devices as well as with plastic ...
Combination treatment protocols including BoNT-A demonstrate higher patient satisfaction and retention rates compared to monotherapy or sequential treatments. Some guidelines for sequencing of treatme...
Integrating BoNT-A into a larger aesthetic treatment plan is crucial for achieving natural and satisfying results in facial rejuvenation. Evidence supports better outcomes when incorporating with both...
Gastrointestinal cancers represent a major challenge to public health. Pancreatic cancer is the most lethal cancer among all gastrointestinal cancers. Most patients cannot meet the criteria of resecti...
Neoadjuvant chemotherapy helps some patients regain the opportunity of radical resection. An optimal regimen of chemotherapy is one that maximizes the anti-tumor efficacy while maintaining a relativel...
Combination therapies in a multidisciplinary manner that involves modified chemotherapy regimen, radical resection, and intestine auto-transplantation may provide the currently best possible care to p...
Loop diuretics are the cornerstone of the treatment of volume overload in decompensated heart failure. However, often complete decongestion cannot be achieved rapidly with loop diuretics alone, partly...
Immune checkpoint inhibitors (ICIs) combined with antiangiogenic therapy have limited efficacy in treating advanced hepatocellular carcinoma (HCC). The synergistic effect of systemic therapy and radia...
This retrospective observational study analyzed the medical records of 194 patients with Barcelona Clinic Liver Cancer stage C HCC who were admitted to our center from August 2018 to June 2022 and rec...
A total of 76 patients diagnosed with advanced-stage HCC and treated with ICIs and antiangiogenic therapy were included in the study, with 33 patients in the RT group and 43 patients in the non-RT gro...
In comparison to the combination of ICIs and antiangiogenic therapy, the inclusion of RT has been observed to improve the DCR and survival outcomes in patients with advanced-stage HCC. The safety prof...
Patterned hair loss is a common type of non-scarring alopecia, characterized by miniaturization of hair follicles. The etiology of female pattern hair loss (FPHL) is not clearly linked to androgens or...